[1]吴震宇.核素显像在肝癌临床诊断中的应用[J].国际放射医学核医学杂志,2004,28(5):199-202.
　WU Zhen-yu.The clinical application of nuclein scanning in liver carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):199-202.
点击复制

核素显像在肝癌临床诊断中的应用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
28
期数:
2004年第5期
页码:
199-202
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The clinical application of nuclein scanning in liver carcinoma
作者:
吴震宇
200025 上海, 上海第二医科大学附属瑞金医院核医学科
Author(s):
WU Zhen-yu
Department of Nuclear Medicine, RuiJin Hospital of Shanghai Second Medical University, Shanghai 200025, China
关键词:
肝癌; 单光子发射计算机体层显像; 正电子发射计算机体层显像; 18F-氟代脱氧葡萄糖; 11C-乙酸盐
Keywords:
liver carcinoma; single positron emission computed tomography; positron emission tomography; 18F-fluorodeoxyglucose; 11C-acetate
分类号:
R817.4
摘要:
核素显像方法(包括SPECT、PET及PET/CT)对于原发性肝癌的诊断、良恶性鉴别及分化程度的评估有重要价值,尤其是18F-FDG(18F-氟代脱氧葡萄糖)PET及11C-乙酸盐PET在评价肿瘤分化程度的作用优于CT、MRI。PET/CT的应用也将弥补PET在空间分辨率上存在的不足,提高肝癌诊断的准确性。
Abstract:
All kinds of nuclein scanning includeing SPECT、PET and PET/CT in liver carcinoma have a definite clinical impact on diagnosis,differential diagnosis between malignant and benign tumor,and evaluation of differentiation of tumor cell. Especially fluorine-18-deoxyglucose PET and carbon-11-acetate PET play a more important role in assessement of differentiation of liver carcinoma than CT and MRI. Combined with the examinations of morphology, PET/CT will provide better imaging effect for lesion’ localization and characterization.

参考文献/References:

1 Ho YJ,Jen LB,Yang M D,et al.Usefulness of technetium-99m methoxyisobutylisonitrile liver single photon emission computed tomography to detect hepatocellular carcinoma[J].Neoplasma,2003,50(2):117-119.
2 Fukushima K,Kono M,Ishii K,et al.Technetium-99m methoxy-isobutylisonitrile single photon emission tomography in hepatocellular carcinoma[J].Eur J Nucl Med,1997,24(11):1426-1428.
3 Kempf JS,Hudak R,Abdel-Dayem HM,et al.201Tl chloride SPECT imaging of hepatocellular carcinoma[J].Clin Nucl Med,1996,21(12):953-957.
4 Mochizuki T,Takechi T,Murase K,et al.Thallium-201/technetium-99m-phytate (colloid) subtraction imaging of hepatocellular carcinoma[J].J Nucl Med,1994,35(7):1134-1137.
5 Verhoef C,Valkema R,de Man R A,et al.Fluorine-18FDG imaging in hepatocellular carcinoma using positron coincidence detection and single photon emission computed tomography[J].Liver,2002,22(1):51-56.
6 Wudel LJ,Delbeke D,Morris D,et al.The role of[18F]fluorode-oxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma[J].Am Surg,2003,69(2):117-126.
7 Iwata Y,Shiomi S,Sasaki N,et al.Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors[J].Ann Nucl Med,2000,14(2):121-126.
8 Son HB,Han CJ,Kim BI,et al.Evaluation of various hepatic lesions with positron emission tomography[J].Taehan Kan Hakhoe Chi,2002,8(4):472-480.
9 Trojan J,Schroeder O,Raedle J,et al.Fluorine-18FDG positron emission tomography for imaging of hepatocellular carcinoma[J].Am J Gastroenterol,1999,94(11):3314-3319.
10 Khan MA,Combs CS,Brunt EM,et al.Positron emission tomography scanning in the evaluation of hepatocellular carcinoma[J].J Hepatol,2000,32(5):792-797.
11 Okazumi S,Isono K,Enomoto K,et al.Evaluation of liver tumorsusing fluorine-18-fluorodeoxyglucose PET:characterization of tumor and assessment of effect of treatment[J].J Nucl Med,1992,33(3):333-339
12 Ho CL,Yu SC,Yeung D W.11C-acetate PET imaging in hepatocellular carcinoma and other liver masses[J].J Nucl Med,2003,44(2):213-221.

相似文献/References:

[1]郭雷鸣.SPECT在内照射剂量学中的应用[J].国际放射医学核医学杂志,2004,28(2):67.
　GUO Lei-ming.The applications of SPECT in internal dosimetry[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):67.
[2]陈小明.SPECT在冠心病危险度分层方面的应用[J].国际放射医学核医学杂志,2004,28(3):101.
　CHEN Xiao-ming.Risk stratification assessed by single photon emission computed tomography in coronary artery disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(5):101.
[3]温广华.18F-FDG PET显像在肝癌中的应用[J].国际放射医学核医学杂志,2003,27(1):21.
　WEN Guang-hua.The applications of 18F-FDG PET in liver carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(5):21.
[4]鞠永健.90Y微球治疗肝癌的剂量估算方法现状[J].国际放射医学核医学杂志,2002,26(3):134.
　JU Yong-jian.The methods of dose estimation about the treatment with 90Y-microspheres in liver malignancy[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(5):134.
[5]川玲.应用18F-FDGSPECT检测存活心肌[J].国际放射医学核医学杂志,2002,26(4):156.
　CHUAN Ling.Assessment myocardial viability by18-fluorodeoxyglucose imaging sin gle photon emission computed tomography[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(5):156.
[6]张凯军.SPECT脑血流及介入显像在痴呆诊断中的临床应用进展[J].国际放射医学核医学杂志,2002,26(4):159.
　ZHANG Kai-jun.Clinical advances of SPECT rCBF and interventional imaging applied in the diagnosis of dementias[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(5):159.
[7]许长德.探测心肌活力的技术进展[J].国际放射医学核医学杂志,2002,26(6):263.
　XU Chang-de.The development of imaging methods detecting the myocardial viability[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(5):263.
[8]童冠圣.核素标记微球治疗肝癌的实验与临床研究[J].国际放射医学核医学杂志,2000,24(3):116.
　TONG Guan-sheng.Experimental and clinical study on radionuclide-lablled microspheres in treating hepatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(5):116.
[9]傅尚志,张楚毅.肝癌内照射临床及实验研究进展[J].国际放射医学核医学杂志,1996,20(5):202.

备注/Memo

备注/Memo:
收稿日期:2004-01-16。
更新日期/Last Update: 1900-01-01